PF-01247324

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamePF-01247324
Drug Alias NamePF-01247324
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsChronic Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsChronic Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A